IM PGY-3 @mhshospital 🇺🇸 | Cardiology @Dante_Pazzanese 🇧🇷 | Cardiology Fellowship Applicant (ID: 16007586) 🇺🇸 | @ASPCardio Social Media Ambassador.
Joined February 2023
- Tweets196
- Following1.1K
- Followers193
- Likes8.1K
Pinned Tweet
Excited to share that I’m officially applying for Cardiology Fellowship! Looking forward to the upcoming interview season. I’m incredibly grateful to the support from everyone up until this point.
AAMC ID: 16007586
#CardiologyFellowship #CardioTwitter #Match2027 #MedTwitter
❤️ A patient now meets criteria for biomarker-defined pre-HF. What should change in care?
Following the study Drs. @sohailszahid & @MichaelJBlaha share an exciting editorial @AJPCardio “The Signal Before the Syndrome,” focusing on the clinical decisions that come next.
8/ A screening strategy should be judged by its consequences.
The editorial calls for evidence on effectiveness, risks, feasibility and cost-effectiveness, including effects on quality of life and mortality.
Those outcomes should guide the next phase.
9/ ✍️The takeaway: how to pair pre-HF detection with a practical plan for care?
Thank you to author for this insightful discussion.
Read Full Text: doi.org/10.1016/j.ajpc.2026.…
@AJPCardio @khurramn1
#HeartFailure #Prevention #CKM
❤️Are we missing pre-heart failure when we rely on echo alone?
A pooled analysis of 11,426 adults examines what cardiac biomarkers add to Stage B identification and HF risk prediction.
@AJPCardio
11/ ⚠️ Important limitations
• Observational design
• Single time point baseline measurements
• Different assays and incomplete echo measures across cohorts
• Selected analytic population
➡️ The study did not test whether treating biomarker-defined pre-HF prevents HF.
12/ ❤️ Key message
Biomarkers may identify pre-HF risk missed by echo-only staging.
Biomarker + echo abnormalities mark the highest-risk group.
Congratulations to the authors @NeilKeshvani @ambarish4786 and team!
Full Text Link: sciencedirect.com/science/ar…
#HeartFailure